Press Releases about Incyte Corp
![](https://mms.businesswire.com/media/20240709787662/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240708590802/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20240613667141/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
Incyte Announces Final Results of Tender Offer
June 13, 2024
From Incyte Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240611735162/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
Incyte Announces Preliminary Results of Tender Offer
June 11, 2024
From Incyte Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240607833063/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20240530903016/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240521531442/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240521754461/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240514560354/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240513823141/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240502751076/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240430048388/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240423725958/en/2106269/22/escient-logo_%28003%29.jpg)
![](https://mms.businesswire.com/media/20240411369652/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240401280916/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240329198758/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20240310012701/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240310275231/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240304329736/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240229692531/en/2050221/5/TUJ_VOMPN_Logo_Primary.jpg)
![](https://mms.businesswire.com/media/20240227083647/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240215941438/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240213408157/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20240205431773/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
February 05, 2024
From Incyte
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg)
![](https://mms.businesswire.com/media/20240123747153/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
January 23, 2024
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20240108325409/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
![](https://mms.businesswire.com/media/20231212377485/en/1078784/22/Incyte_Color_Logo_JPEG_2colorpos.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.